Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Risk Factors for Incident Hypertension Within 1 Year of Initiating Antiretroviral Therapy Among People with HIV.  AIDS Research and Human Retroviruses.  38:735-742. 2022
2019 Mental health disorders and alcohol use are associated with increased likelihood of smoking relapse among people living with HIV attending routine clinical care.  BMC Public Health.  19. 2019
2019 Erectile Dysfunction Medication Prescription: STI and Risk Behavior in Men with HIV 2019
2019 Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patients.  International Journal of STD and AIDS.  30:344-352. 2019
2018 Reconciling the evaluation of co-morbidities among HIV care patients in two large data systems: the Medical Monitoring Project and CFAR Network of Integrated Clinical Systems. 2018
2018 Trends in utilization of statin therapy and contraindicated statin use in HIV-infected adults treated with antiretroviral therapy from 2007 through 2015.  Journal of the American Heart Association.  7. 2018
2018 Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.  AIDS Research and Human Retroviruses.  34:916-921. 2018
2018 Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.  Journal of Clinical Lipidology.  12:988-998.e5. 2018
2018 Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States.  PLoS One.  13. 2018
2017 Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women 2017
2017 Correction to: Prevalence odds ratio versus prevalence ratio: choice comes with consequences: Prevalence odds ratio versus prevalence ratio (Statistics in Medicine, (2016), 35, 30, (5730-5735), 10.1002/sim.7059).  Statistics in Medicine.  36:3760. 2017
2017 Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared with the General Population 2017
2017 A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.  AIDS and Behavior.  21:1975-1984. 2017
2017 Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.  AIDS and Behavior.  21:1914-1925. 2017
2017 Race and sex differences in ambulatory blood pressure measures among HIV+ adults.  Journal of the American Society of Hypertension.  11:420-427.e3. 2017
2017 Associations between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy among Patients Living with HIV.  AIDS Research and Human Retroviruses.  33:534-545. 2017
2017 Types of myocardial infarction among human immunodeficiency virus–infected individuals in the United States.  JAMA Cardiology.  2:260-267. 2017
2017 Not all non-drinkers with HIV are equal: demographic and clinical comparisons among current non-drinkers with and without a history of prior alcohol use disorders* 2017
2017 Brief Report: Factors Associated with the Selection of Initial Antiretroviral Therapy from 2009 to 2012 2017
2016 Prevalence odds ratio versus prevalence ratio: choice comes with consequences.  Statistics in Medicine.  35:5730-5735. 2016
2016 Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.  Sexually Transmitted Diseases.  43:483-488. 2016
2016 Suitability of the PROMIS alcohol use short form for screening in a HIV clinical care setting.  Drug and Alcohol Dependence.  164:113-119. 2016
2016 Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy among HIV-infected Patients Followed for up to 15 Years after Start of Treatment: Collaborative Cohort Study.  Clinical Infectious Diseases.  62:1571-1577. 2016
2016 Unanticipated effects of new drug availability on antiretroviral durability: Implications for comparative effectiveness research.  Open Forum Infectious Diseases.  3. 2016
2016 Ambulatory blood pressure monitoring in individuals with HIV: A systematic review and meta-analysis.  PLoS One.  11. 2016
2016 Predictors of HIV Disclosure in Infected Persons Presenting to Establish Care.  AIDS and Behavior.  20:147-154. 2016
2015 Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV.  Current Hypertension Reports.  17. 2015
2015 Venous thromboembolism among HIV-positive patients and anticoagulation clinic outcomes integrated within the HIV primary care setting.  International Journal of STD and AIDS.  26:870-878. 2015
2015 Achieving Core Indicators for HIV Clinical Care among New Patients at an Urban HIV Clinic 2015
2015 Obesity is Associated with Race/Sex Disparities in Diabetes and Hypertension Prevalence, but Not Cardiovascular Disease, among HIV-Infected Adults.  AIDS Research and Human Retroviruses.  31:898-904. 2015
2015 An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial 2015
2015 Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care..  Journal of AIDS and Clinical Research.  6. 2015
2015 Short communication: Viral suppression is associated with increased likelihood of colorectal cancer screening among persons living with HIV/AIDS.  AIDS Research and Human Retroviruses.  31:519-524. 2015
2015 Self-report measures in the assessment of antiretroviral medication adherence: Comparison with medication possession ratio and HIV viral load.  Journal of the International Association of Providers of AIDS Care.  14:156-162. 2015
2015 Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients..  AIDS.  29:373-383. 2015
2015 Fructosamine and hemoglobin a1c correlations in HIV-infected adults in routine clinical care: Impact of anemia and albumin levels.  AIDS Research and Treatment.  2015. 2015
2014 Letters to the editor.  American Journal of Epidemiology.  180:450. 2014
2014 Lymphoma immune reconstitution inflammatory syndrome in the center for AIDS research network of integrated clinical systems cohort.  Clinical Infectious Diseases.  59:279-286. 2014
2014 Reply to rapose.  Clinical Infectious Diseases.  59:316-317. 2014
2014 Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.  Clinical Infectious Diseases.  58:1312-1321. 2014
2014 Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.  American Journal of Epidemiology.  179:996-1005. 2014
2014 Church attendance in men who have sex with men diagnosed with HIV is associated with later presentation for HIV care.  Clinical Infectious Diseases.  58:295-299. 2014
2014 Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients.  AIDS.  28:2627-2631. 2014
2014 HIV-Related Metabolic Comorbidities in the Current ART Era.  Infectious Disease Clinics of North America.  28:457-476. 2014
2014 The authors reply..  American Journal of Epidemiology.  180:450. 2014
2013 Association of early HIV viremia with mortality after HIV-associated lymphoma.  AIDS.  27:2365-2373. 2013
2013 Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era 2013
2012 Multimorbidity patterns in HIV-infected patients: The role of obesity in chronic disease clustering 2012
2012 Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients.  Clinical Infectious Diseases.  55:1550-1557. 2012

Research Overview

  • Cardiovascular diseases and related co-morbidities in persons living with HIV

    • Principal Investigator On

    Investigator On

  • 1-3/3 COMpAAAS Tripartite: ART-CC, KP, and VA  awarded by University of Bristol
  • 3/3 Alcohol Research Consortium in HIV - Intervention Research Arm (ARCH-IRA)  awarded by National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
  • 3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)  awarded by UNIVERSITY OF WASHINGTON
  • ARCH-ERA Alcohol Research Consortium in HIV-Epidemiological Research Arm  awarded by UNIVERSITY OF WASHINGTON
  • CFAR Network of Integrated Clinical Systems (CNICS)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Development of a Behavioral Intervention for Chronic Pain in Individuals with HIV  awarded by National Institute of Mental Health/NIH/DHHS
  • HIV+ Service Delivery and Telemedicine Through Effective PROs  awarded by National Institute of Mental Health/NIH/DHHS
  • Integration of Evidence-Based Alcohol Interventions into HIV Care  awarded by National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS
  • North American - AIDS Cohort on Collaboration and Design (NAACCORD)  awarded by JOHNS HOPKINS SCHOOL OF MEDICINE
  • North American AIDS Cohorts Collaboration on Research and Design (NA-ACCORD) Johns Hopkins Subcontract  awarded by Johns Hopkins University
  • North American AIDS Cohorts on Collaboration and Design (NAACCORD)  awarded by Johns Hopkins University
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by AMGEN, INC.^
  • Southeast Regional AIDS Education and Training Center  awarded by VANDERBILT UNIVERSITY
  • Tissue and Organ Specific Human B Cell Immunity  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Tissue and Organ Specific Human B Cell Immunity - Supplement - Metabolic Risk Factors and Inflammation in PASC Development  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research (CFAR)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research (CFAR)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research (CFAR) - EHE Implementation Science Consultation Hub  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research - Clinical Core (Core C)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for AIDS Research - Lipidomic Profiling in HIV Patients Newly Initiating Antiretroviral Treatment  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • UAB Center for Clinical and Translational Science (CCTS) (3 Linked Awards UL1, KL2, TL1)  awarded by National Center for Advancing Translational Sciences/NIH/DHHS

    • Education And Training

  • Beth Israel Medical Center, Residency
  • UAB Hospital, Postdoctoral Fellowship
  • Master of Science in Public Health, University of Alabama at Birmingham 2012
  • Doctor of Medicine in Internal Medicine Residency Program, University of South Florida 2005

    • Full Name

  • Greer Burkholder